showing that patients who developed a greater increase in depressive symptoms during pegIFN-a2b and ribavirin treatment were less likely to show virologic response at the end of the treatment. As Raison et al 9 suggest, a persisting or less responsive virus could cause worse fatigue and depression by inducing inflammation and immune activation. However, it is also possible that the worse fatigue or depression and the lack of response are both associated with a third factor, for example, MHC class II genotypes regulating the immune response. Finally, patients who experience worse fatigue and depression could be less compliant with therapy, and future studies should measure plasma concentrations of the antiviral agents to clarify this point.
It is of note that Loftis et al 10 described results that are apparently in contrast with our work and the work by Raison et al. 9 In fact, they found that depression is associated with increased virologic response to (nonpegylated) IFN-a and ribavarin treatment. 10 An important difference in the study by Loftis et al 10 is that all patients who reached a threshold for depression were started on antidepressant treatment; in our study, and in the study by Raison et al, 9 the antidepressant treatment was dictated by clinical judgment of patient's distress. This 'assertive' approach explains the high rate of patients receiving antidepressants in the study by Loftis et al: 13 out of 39 subjects (33%), 10 vs three out of 29 (10%) in our study, and five out of 60 (8%) in our previous study on a different sample using similar clinical guidelines. [1] [2] [3] It is possible that the antidepressant treatment-rather that the depression-explains the better virologic response rate, as the antidepressant treatment may allow better compliance and prevent reductions in the doses of IFN-a and ribavarin. We believe that clarifying the mechanisms by which IFN-a induces psychopathological symptoms will help understanding not only the predictors of the psychiatric outcome but also the predictors of the therapeutic outcome. SIR-The paradox of human altruism, helping others and thereby reducing one's own fitness, has confounded evolutionary biologists since the days of Darwin.
1 Nevertheless, altruistic behavior is commonplace and a unique feature of human altruism is that it extends beyond Hamilton's concept of 'inclusive fitness', which explains altruistic acts by including helping genetically related individuals, and even beyond reciprocal altruism and reputation-based altruism. However, almost nothing is known regarding specific genes contributing to this behavior despite twin studies 2 demonstrating that a significant proportion of the differences between people regarding prosocial attitudes is due to heredity.
Towards the goal of identifying specific genes associated with altruism, 354 nonclinical families with multiple siblings were inventoried for scores on the Selflessness Scale. 3 This questionnaire measures the propensity to ignore ones own needs and serve the needs of others, or in other words altruism. Subjects were also inventoried on Cloninger's TPQ 4 since the Reward subscale of this questionnaire taps into elements of human altruism such as empathy. We examined two dopaminergic genes in these subjects that we hypothesized might contribute to prosocial or altruistic traits based on the role a single variant of these genes plays in attention deficit hyperactivity disorder (ADHD), often comorbid with antisocial behavior. Meta-analyses 5, 6 show that the dopamine D4 receptor (DRD4) exon III 7 repeat (D4.7) and the DRD5 148 bp microsatellite variant have both been associated with ADHD in some but not all studies. We reasoned that if one variant contributes to antisocial traits, then conversely the absence of this variant or We tested for presence of association between various polymorphisms and scores on the questionnaires, using the family-based association test (FBAT) http://www.biostat.harvard.edu/Bfbat/fbat.htm, which allows for inclusion of both triads and extended families in the analysis and is adjusted for population admixture. 10 All markers were in Hardy-Weinberg equilibrium (using Merlin). 'afreq' is allele frequency. 'fam#' is the number of informative families, that is, families with at least one heterozygote parent. S is the test statistic for the observed number of transmitted alleles. E(s) is the expected value of S under the null hypothesis of no association in the presence of linkage. The values for KIN, NON-KIN and NON-CARING were adjusted for sex and age. The original Selflessness questionnaire consists of 15 items. We undertook factor analysis on 1006 subjects. Using Principal Component Analysis (Promax rotation with Kaiser normalization), we found a three component solution (KIN, NON-KIN, NON-CARING) that accounted for B38% of the variance. Reliability analysis gave an alpha Chronbach ¼ 0.63, which compares favorably with the original description of this scale (alpha ¼ 0.61). Genotyping methods and details on the questionnaire are available from the corresponding author on request.
Scientific Correspondence the presence of other variants might contribute to altruistic behavior. We also genotyped three SNPs 7 in the insulin-like growth factor 2 gene (IGF2), an imprinted gene on chromosome 11p15.5 that is an attractive candidate since some studies connect this class of growth factors to survival of dopamine neurons specifically 8 and with neural development overall.
As shown in Table 1 , significant multivariate associations were observed between the Selflessness Scale and the DRD4 exon III (D4.4), the IGF2 Apa I ('G') and DRD5 (146 and 148 bp repeat) polymorphisms. Univariate analysis also showed significant associations with the most common D4.4 allele, the IGF2 ApaI ('G' allele) and DRD5 (148 bp repeat, negatively associated) for all three factors (KIN, NON-KIN and NON-CARING). We also found a significant association (P ¼ 0.002) between the D4 4/4 genotype and TPQ reward (data not shown). No association was observed between three DRD4 promoter region polymorphisms, including the ÀC521T SNP, nor with any haplotypes (data not shown). Haplotype analysis of the three IGF2 SNPs was slightly more informative than single SNP analysis (data not shown).
We conjecture that the balanced maintenance of both the D4.4 and D4.7 repeats in human evolution 9 is related to the need for diverse behavioral phenotypes in human populations partially determined by this gene, altruistic and prosocial (D4.4) vs a more aggressive, novelty seeking or perhaps even antisocial type (D4.7). All three genes (DRD4, IGF2 and DRD5) in the current study were associated with both the KIN and NON-KIN subscales. These results suggest the notion that the genetic architecture of altruism in humans is partly built from genes that drive an altruistic behavioral pattern regardless of kin considerations. It would be of interest whether there are KIN/NON-KIN-specific polymorphisms, as well. We also suggest the notion that the linkage between reward and altruistic attitudes provide the neurochemical substrate and 'hard wiring' needed to drive acts that benefit others even at the expense of reducing one's own fitness. We 'feel good' and rewarded by a dopamine pulse when doing good deeds. Selection for specific polymorphisms that 'reward' altruistic acts via brain dopaminergic pathways is the grist for the evolutionary mill.
